Ballentine Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Sell |
1,137
-341
| -23% | -$183K | 0.01% | 428 |
|
|
2025
Q1 | $621K | Buy |
1,478
+253
| +21% | +$106K | 0.01% | 383 |
|
|
2024
Q4 | $506K | Sell |
1,225
-19
| -2% | -$7.86K | 0.01% | 420 |
|
|
2024
Q3 | $628K | Sell |
1,244
-38
| -3% | -$19.2K | 0.01% | 371 |
|
|
2024
Q2 | $625K | Buy |
1,282
+94
| +8% | +$45.8K | 0.01% | 359 |
|
|
2024
Q1 | $641K | Buy |
1,188
+22
| +2% | +$11.9K | 0.01% | 340 |
|
|
2023
Q4 | $647K | Buy |
1,166
+622
| +114% | +$345K | 0.01% | 313 |
|
|
2023
Q3 | $238K | Buy |
544
+5
| +0.9% | +$2.19K | 0.01% | 500 |
|
|
2023
Q2 | $271K | Buy |
539
+13
| +2% | +$6.53K | 0.01% | 468 |
|
|
2023
Q1 | $263K | Sell |
526
-685
| -57% | -$343K | 0.01% | 451 |
|
|
2022
Q4 | $494K | Buy |
+1,211
| New | +$494K | 0.01% | 283 |
|
|
2022
Q1 | – | Sell |
-534
| Closed | -$351K | – | 492 |
|
|
2021
Q4 | $351K | Buy |
+534
| New | +$351K | 0.01% | 338 |
|
|
2020
Q4 | – | Sell |
-775
| Closed | -$304K | – | 397 |
|
|
2020
Q3 | $304K | Buy |
775
+2
| +0.3% | +$785 | 0.01% | 292 |
|
|
2020
Q2 | $255K | Buy |
+773
| New | +$255K | 0.01% | 306 |
|
|
2019
Q4 | – | Sell |
-770
| Closed | -$210K | – | 412 |
|
|
2019
Q3 | $210K | Sell |
770
-6
| -0.8% | -$1.64K | 0.01% | 365 |
|
|
2019
Q2 | $214K | Buy |
+776
| New | +$214K | 0.01% | 350 |
|